Abstract

N-terminal acetylation (Nt-acetylation) occurs on the majority of eukaryotic proteins and is catalyzed by N-terminal acetyltransferases (NATs). Nt-acetylation is increasingly recognized as a vital modification with functional implications ranging from protein degradation to protein localization. Although early genetic studies in yeast demonstrated that NAT-deletion strains displayed a variety of phenotypes, only recently, the first human genetic disorder caused by a mutation in a NAT gene was reported; boys diagnosed with the X-linked Ogden syndrome harbor a p.Ser37Pro (S37P) mutation in the gene encoding Naa10, the catalytic subunit of the NatA complex, and suffer from global developmental delays and lethality during infancy. Here, we describe a Saccharomyces cerevisiae model developed by introducing the human wild-type or mutant NatA complex into yeast lacking NatA (NatA-Δ). The wild-type human NatA complex phenotypically complemented the NatA-Δ strain, whereas only a partial rescue was observed for the Ogden mutant NatA complex suggesting that hNaa10 S37P is only partially functional in vivo. Immunoprecipitation experiments revealed a reduced subunit complexation for the mutant hNatA S37P next to a reduced in vitro catalytic activity. We performed quantitative Nt-acetylome analyses on a control yeast strain (yNatA), a yeast NatA deletion strain (yNatA-Δ), a yeast NatA deletion strain expressing wild-type human NatA (hNatA), and a yeast NatA deletion strain expressing mutant human NatA (hNatA S37P). Interestingly, a generally reduced degree of Nt-acetylation was observed among a large group of NatA substrates in the yeast expressing mutant hNatA as compared with yeast expressing wild-type hNatA. Combined, these data provide strong support for the functional impairment of hNaa10 S37P in vivo and suggest that reduced Nt-acetylation of one or more target substrates contributes to the pathogenesis of the Ogden syndrome. Comparative analysis between human and yeast NatA also provided new insights into the co-evolution of the NatA complexes and their substrates. For instance, (Met-)Ala- N termini are more prevalent in the human proteome as compared with the yeast proteome, and hNatA displays a preference toward these N termini as compared with yNatA.

Highlights

  • From the ‡Department of Medical Protein Research, VIB, B-9000 Ghent, Belgium; §Department of Biochemistry, Ghent University, B-9000 Ghent, Belgium; ¶Department of Molecular Biology, University of Bergen, N-5020 Bergen, Norway; ʈDepartment of Clinical Science, University of Bergen, N-5020 Bergen, Norway; and **Department of Surgery, Haukeland University Hospital, N-5021 Bergen, Norway

  • To determine if ectopically expressed hNatA S37P is capable of suppressing the yeast NatA-⌬ phenotypes, hNAA15 was expressed with hNAA10 or hNAA10 S37P in yeast, to respectively generate a yeast strain expressing hNatA (y[hNatA]) or mutant human NatA (y[hNatA S37P]) (Figs. 1A and 1B)

  • HNatA S37P Displays a Reduced hNaa10-hNaa15 Complex Formation, and a Reduced Catalytic Activity In Vitro—Yeast studies revealed that the catalytic subunit Naa10 associates with the ribosome through its interaction with the auxiliary subunit Naa15 where it is brought in close proximity to its nascent polypeptide substrates [51]

Read more

Summary

Introduction

From the ‡Department of Medical Protein Research, VIB, B-9000 Ghent, Belgium; §Department of Biochemistry, Ghent University, B-9000 Ghent, Belgium; ¶Department of Molecular Biology, University of Bergen, N-5020 Bergen, Norway; ʈDepartment of Clinical Science, University of Bergen, N-5020 Bergen, Norway; and **Department of Surgery, Haukeland University Hospital, N-5021 Bergen, Norway. Quantitative Nt-acetylome Analyses Reveal a Reduced Degree of Nt-acetylation for the Majority of NatA Substrates in the hNatA S37P Yeast Strain—Because phenotypic characterization in yeast disclosed a significantly impaired functionality of hNatA S37P in addition to a reduced complex formation and enzymatic activity when assaying the immunoprecipitated hNatA S37P, the in vivo outcome on the steady-state levels of protein Nt-acetylation was studied.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.